Teva suffers trial loss in New York’s landmark opioid case
Teva suffers trial loss in New York’s landmark opioid case [...]
To buy or not to buy? Samsung unit denies report about Biogen talks
To buy or not to buy? Samsung unit denies report [...]
Biogen’s rollercoaster 2021 takes another surprising turn with report of $42B Samsung buyout interest
Biogen’s rollercoaster 2021 takes another surprising turn with report of [...]
Biogen’s roller coaster 2021 takes another surprising turn with report of $42B Samsung buyout interest
Biogen’s roller coaster 2021 takes another surprising turn with report [...]
Bristol Myers Squibb, Amgen and Pfizer approach steepest patent cliffs among large drugmakers
Bristol Myers Squibb, Amgen and Pfizer approach steepest patent cliffs [...]
Leo Pharma gains FDA nod for eczema drug Adbry, but can it challenge Sanofi and Regeneron’s formidable Dupixent?
Leo Pharma gains FDA nod for eczema drug Adbry, but [...]
Merck, Ridgeback clinch FDA’s 2nd emergency nod for a COVID-19 antiviral pill
Merck, Ridgeback clinch FDA’s 2nd emergency nod for a COVID-19 [...]
Pfizer’s megablockbuster-to-be COVID pill Paxlovid scores FDA nod
Pfizer’s megablockbuster-to-be COVID pill Paxlovid scores FDA nod esagonowsky Wed, [...]
Biogen, Eisai face down another Aduhelm refusal—this time from Japanese regulators
Biogen, Eisai face down another Aduhelm refusal—this time from Japanese [...]
Particulate problem prompts hold on 10 Gilead studies of HIV hopeful lenacapavir
Particulate problem prompts hold on 10 Gilead studies of HIV [...]